President Trump's latest technique to sort out excessive drug costs is meant to hyperlink the worth of American medicines to the costs paid for a similar merchandise in different international locations, a so -called 'most beneficiary' coverage that was beforehand introduced however by no means got here into drive. Pharmaceutical corporations are already confronted with worth negotiations for chosen merchandise […]
